Provisional vaccine uptake for the first routine cohort eligible for infant Meningococcal B immunisation is 95.7% for one dose and 82.4% for two doses by six months of age.
Meningococcal B (MenB) vaccination was introduced from 1 September 2015 for infants due to receive their primary immunisations starting at two months of age on or after 1 September 2015 (i.e. those babies born on or after 1 July 2015). The vaccine is offered alongside other routine immunisations at two and four months of age, with a booster dose at 12-13 months. A limited oneoff catch-up programme was also delivered targeting infants born in May and June 2015 receiving other routine immunisations. This report describes the first MenB provisional vaccine uptake figures for one and two doses of vaccine received by these cohorts when evaluated at six months (26 weeks) of age.
Further information relating to the implementation of the new MenB immunisation programme is available from:
The data for this publication are derived from the Scottish Immunisation and Recall System (SIRS). This is an electronic system used by all NHS boards in Scotland. The system facilitates the invitation of children when a scheduled immunisation is due and allows recording of immunisation data. After an immunisation contact has taken place the immunisation details are keyed into the system by administrative staff in NHS boards.
The data covers the entire child population in Scotland, i.e. it is not a sample.
ISD receive data extracts from SIRS for the purpose of producing and publishing immunisation uptake rates. The uptake rates are based on all children reaching a specified age who were alive and registered on SIRS at the end of the reporting period.
MenB vaccine uptake was calculated for each of the cohorts in Table 1.
Uptake for the first catch-up cohort (born May 2015), eligible for one dose of MenB vaccine, was 79.7% when evaluated at six months of age.
Uptake for the second catch-up cohort (born June 2015), was 90.1% for one dose and 65.9% for two doses of vaccine when evaluated at six months of age.
Uptake for the first routine cohort (born July 2015) was 95.7% for one dose and 82.4% for two doses of vaccine at six months of age.
Preliminary vaccine uptake at six months of age for the new infant MenB programme indicates the vaccine has been accepted and delivered well, with high uptake achieved in both catch-up cohorts and the first routine cohort eligible for vaccination. Infants born after 1 July 2015 who were not vaccinated at six months of age continue to be eligible for their primary immunisations and it is anticipated that uptake in this cohort will increase when evaluated at 12 months of age.
The first quarterly routine immunisation statistics to include MenB uptake will be published in December 2016, for children reaching age 12 months in the quarter July to September 2016.
The introduction of MenB immunisation has been supported by many different NHS organisations and healthcare practitioners across Scotland, whose hard work is gratefully acknowledged.